GMED - Globus Medical logo

Globus Medical

GMED
Revenue grew 100% of years10Y
Compare GMED Hold

Globus Medical develops and commercializes healthcare solutions for musculoskeletal disorders, offering spine products, orthopedic trauma solutions, arthroplasty systems, robotic guidance platforms, and biological treatments sold to healthcare providers globally.

โš•๏ธ Healthcare NYSE Listed 2012 $ USD
$1,000 invested 10 years ago โ†’$3,526today

Score Overview

1 Year
Score
Net Growth-0.45%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth7.01%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score7.1
Net Growth258.91%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth228.24%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth413.19%
Net Trend50%
Net Income Consistency
Rev Growth457.61%
Rev TrendEvery year
Revenue Consistency
All Time
Score
Net Growth7x
Net Trend50%
Net Income Consistency
Rev Growth8x
Rev TrendEvery year
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Globus Medical has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. GMED does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 81.41โ€”
1 Year2025-10-23
$ 62.8029.63%
5 Years2021-10-22
$ 79.921.86%
10 Years2016-10-21
$ 23.09252.58%
All Time2012-08-03
$ 13.506x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 3.14B$ 535M$ 595M
2025$ 2.93B$ 537M$ 557M
2024$ 2.51B$ 102M$ 890M
2023$ 1.56B$ 122M$ 517M
2022$ 1.02B$ 190M$ 446M
2021$ 958M$ 149M$ 443M
2020$ 789M$ 102M$ 426M
2019$ 785M$ 155M$ 311M
2018$ 712M$ 156M$ 339M
2017$ 635M$ 107M$ 373M
2016$ 563M$ 104M$ 290M
2015$ 544M$ 112M$ 281M
2014$ 474M$ 92M$ 228M
2013$ 434M$ 68M$ 238M
IPO2012$ 385M$ 73M$ 212M
GMED - Globus Medical logo

Globus Medical fundamental performance

Between 2020 and 2025, revenue grew from $ 789M to $ 2.93B and net income grew from $ 102M to $ 537M. Revenue increased in every one of those 5 years; net income in 2.

Between 2015 and 2025, revenue grew from $ 544M to $ 2.93B and net income grew from $ 112M to $ 537M. Revenue increased in every one of those 10 years; net income in 5.

Globus Medical currently holds a 5-year HDB Score of 7.1 out of 10. How the HDB Score is calculated.

Membership

Explore GMED with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies